Quantamental Technologies LLC Seres Therapeutics, Inc. Transaction History

Quantamental Technologies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$6.3 - $8.84 $135,324 - $189,883	-21,480 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$6.02 - $11.43 $24,940 - $47,354	4,143 Added 23.9%	21,480 $179,000
Q3 2021 Nov 15, 2021	BUY	$5.46 - $22.6 $94,660 - $391,816	17,337 New	17,337 $121,000
Q4 2019 Feb 14, 2020	SELL	$2.99 - $4.42 $4,730 - $6,992	-1,582 Closed	0 $0
Q3 2019 Nov 08, 2019	SELL	$2.29 - $4.16 $687 - $1,248	-300 Reduced 15.94%	1,582 $6,000
Q2 2019 Aug 12, 2019	BUY	$2.28 - $7.35 $4,290 - $13,832	1,882 New	1,882 $6,000

46.3M

119K

466K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $114M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantamental Technologies LLC with notifications on news.